At-Home vs. In-Clinic Administration of Cabenuva for Treatment of HIV Infection

Date Added
August 17th, 2021
PRO Number
Pro00110879
Researcher
Eric Meissner

List of Studies


Keywords
HIV / AIDS
Summary

Adult patients (18 years and older) who receive treatment for HIV in the MUSC Infectious Diseases Clinic will be offered participation in this study. This study will asses whether receipt of injectable HIV therapy at home with a Home Health provider is as safe and effective as receiving treatment in clinic. Participants receiving injectable HIV therapy prescribed by their primary HIV physician will choose to receive the monthly injection at home or in a clinic setting and will have the option to change where they receive treatment at any time. Questionnaires will be completed at the beginning and end of treatment along with a monthly satisfaction survey. Participation in the study is expected to last approximately 1 year.

Institution
MUSC
Recruitment Contact
Jamila Williams
843-792-1088
keithja@musc.edu

A Phase 2a Multicentre, Randomized, Open-Label, Two-Part Adaptive Design Study to Evaluate the Antiviral Effect, Safety and Tolerability of GSK3810109A, an HIV-1 Specific Broadly Neutralizing Human Monoclonal Antibody in Antiretroviral-naive HIV-1-Infected Adults

Date Added
June 15th, 2021
PRO Number
Pro00110807
Researcher
Eric Meissner

List of Studies


Keywords
HIV / AIDS
Summary

The purpose of this study is to evaluate the safety and efficacy of an investigational drug in adults with a clinical diagnosis of Human Immunodeficiency Virus (HIV). This study aims to determine if receipt of a one-time infusion or sub-cutaneous (under the skin) administration of the study drug results in a longer lasting response against HIV. The study drug will be given in addition to the standard of care treatment. The study of this investigational drug represents a novel approach to the treatment of this condition. Participation in the study will involve a minimum of 10 visits to the study clinic over a period of 1 month, followed by initiation of standard of care treatment.

Institution
MUSC
Recruitment Contact
Lisa Martin
843-876-5699
martinl@musc.edu

Development and Evaluation of a Virtual Reality Tool for At-Risk Trauma-Exposed Young People

Date Added
February 22nd, 2021
PRO Number
Pro00105369
Researcher
Carla Danielson

List of Studies